Mirtazapine overdose is unlikely to cause major toxicity

References

• de Boer T. The pharmacologic profile of mirtazapine. J Clin Psychiatry 1996; 57:19–25.
   PubMed Web of Science ®Google Scholar
• Montgomery SA. Safety of mirtazapine: a review. Int Clin Psychopharmacol 1995; 10:37–45.
   PubMed Web of Science ®Google Scholar
• de Boer T. The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission. Int Clin Psychopharmacolo 1995; 10:19–23.
   PubMed Web of Science ®Google Scholar
• Hernandez JL, Ramos FJ, Infante J, Rebollo M, González-Macías J. Severe serotonin syndrome induced by mirtazapine monotherapy. Ann Pharmacother 2002; 36:641–643.
   PubMed Web of Science ®Google Scholar
• Kuliwaba A. Non-lethal mirtazapine overdose with rhabdomyolysis. Austr N Z J Psychiatry 2005; 39:312–313.
   PubMed Web of Science ®Google Scholar
• Sauvageau A. A suspicious bathtub death in a suicidal patient on mirtazapine. Clin Toxicol 2006; 44:91.
   Web of Science ®Google Scholar
• Salomone A, Di Corcia D, Gerace E, Vincenti M. A fatal case of simultaneous ingestion of mirtazapine, escitalopram, and valproic acid. J Anal Toxicol 2011; 35:519–523.
   PubMed Web of Science ®Google Scholar
• Hoes MJ, Zeijpveld JH. First report of mirtazapine overdose. Int Clin Psychopharmacol 1996; 11:147.
   PubMed Web of Science ®Google Scholar
• Raja M, Azzoni A. Mirtazapine overdose with benign outcome. Eur Psychiatry 2002; 17:107.
   PubMed Web of Science ®Google Scholar
• Garlipp P, Brüggemann BR, Machleidt W. A non-fatal mirtazapine overdose in a suicide attempt.Aust N Z J Psychiatry 2003; 37: 244–245.
   PubMed Web of Science ®Google Scholar
• Holzbach R, Jahn H, Pajonk FG, Mähne C. Suicide attempts with mirtazapine overdose without complications. Biol Psychiatry 1998; 44:925–926.
   PubMed Web of Science ®Google Scholar
• Waring WS, Good AM, Bateman DN. Lack of significant toxicity after mirtazapine overdose: a five-year review of cases admitted to a regional toxicology unit. Clin Toxicol 2007; 45:45–50.
   Web of Science ®Google Scholar
• LoVecchio F, Riley B, Pizon A, Brown M. Outcomes after isolated mirtazapine (Remeron) supratherapeutic ingestions. J Emerg Med 2008; 34:77–78.
   PubMed Web of Science ®Google Scholar
• Berling I, Whyte IM, Isbister GK. Oxycodone overdose causes naloxone responsive coma and QT prolongation. QJM 2013; 106: 35–41.
   PubMed Web of Science ®Google Scholar
• Isbister GK, Friberg LE, Stokes B, Buckley NA, Lee C, Gunja N, et al. Activated charcoal decreases the risk of QT prolongation after citalopram overdose. Ann Emerg Med 2007; 50:593–600, 600 e1–46.
   PubMed Web of Science ®Google Scholar
• Calver L, Dunlop AJ, Isbister GK. Individual patient assessment of methadone-induced QT prolongation with digital holter recording. J Addict Med 2012; 6:92–93.
   PubMed Web of Science ®Google Scholar
• van Gorp F, Whyte IM, Isbister GK. Clinical and ECG effects of escitalopram overdose. Ann Emerg Med 2009; 54:404–408.
   PubMed Web of Science ®Google Scholar
• Kelly CA, Dhaun N, Laing WJ, Strachan FE, Good AM, Bateman DN. Comparative toxicity of citalopram and the newer antidepressants after overdose. J Toxicol Clin Toxicol 2004; 42:67–71.
   PubMed Web of Science ®Google Scholar
• Waring WS, Graham A, Gray J, Wilson AD, Howell C, Bateman DN. Evaluation of a QT nomogram for risk assessment after antidepressant overdose. Br J Clin Pharmacol 2010; 70:881–855.
   PubMed Web of Science ®Google Scholar
• Ubogu EE, Katirji B. Mirtazapine-induced serotonin syndrome. Clin Neuropharmacol 2003; 26:54–57.
   PubMed Web of Science ®Google Scholar
• Demers JC, Malone M. Serotonin syndrome induced by fluvoxamine and mirtazapine. Ann Pharmacother 2001; 35:1217–1220.
   PubMed Web of Science ®Google Scholar
• Benazzi F. Serotonin syndrome with mirtazapine-fluoxetine combination. Int J Geriatr Psychiatry 1998; 13:495–496.
   PubMed Web of Science ®Google Scholar
• Turkel SB, Nadala JG, Wincor MZ. Possible serotonin syndrome in association with 5-HT(3) antagonist agents. Psychosomatics 2001; 42:258–260.
   PubMed Web of Science ®Google Scholar
• Dunkley EJ, Isbister GK, Sibbritt D, Dawson AH, Whyte IM. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM 2003; 96:635–642.
   PubMed Web of Science ®Google Scholar
• Isbister GK, Buckley NA. The pathophysiology of serotonin toxicity in animals and humans: implications for diagnosis and treatment. Clin Neuropharmacol 2005; 28:205–214.
   PubMed Web of Science ®Google Scholar
• Khandat AB, Nurnberger JI Jr, Shekhar A. Possible mirtazapine-induced rhabdomyolysis. Ann Pharmacother 2004; 38:1321.
   PubMed Web of Science ®Google Scholar
• Retz W, Maier S, Maris F, Rösler M. Non-fatal mirtazapine overdose. Int Clin Psychopharmacol 1998; 13:277–279.
   PubMed Web of Science ®Google Scholar
• Friberg LE, Isbister GK, Hackett LP, Duffull SB. The population pharmacokinetics of citalopram after deliberate self-poisoning: a Bayesian approach. J Pharmacokinet Pharmacodyn 2005; 32: 571–605.
   PubMed Web of Science ®Google Scholar
• Kumar VV, Isbister GK, Duffull SB. The effect of decontamination procedures on the pharmacodynamics of venlafaxine in overdose. Br J Clin Pharmacol 2011; 72:125–132.
   PubMed Web of Science ®Google Scholar
• Isbister GK, Friberg LE, Hackett LP, Duffull SB. Pharmacokinetics of quetiapine in overdose and the effect of activated charcoal. Clin Pharmacol Ther 2007; 81:821–827.
   PubMed Web of Science ®Google Scholar